See more : North Springs Resources Corp (NSRS) Income Statement Analysis – Financial Results
Complete financial analysis of Entero Healthcare Solutions Limited (ENTERO.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Entero Healthcare Solutions Limited, a leading company in the industry within the sector.
- LX Technology Group Limited (2436.HK) Income Statement Analysis – Financial Results
- Teixeira Duarte, S.A. (TDSA.LS) Income Statement Analysis – Financial Results
- ITC Limited (ITC.BO) Income Statement Analysis – Financial Results
- KCTech Co., Ltd. (281820.KS) Income Statement Analysis – Financial Results
- RTL Group S.A. (RGLXY) Income Statement Analysis – Financial Results
Entero Healthcare Solutions Limited (ENTERO.NS)
Website: https://www.enterohealthcare.com
About Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, nursing homes, and healthcare clinics in India. It is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. The company was incorporated in 2018 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 39.22B | 33.00B | 25.15B | 17.73B | 13.50B |
| Cost of Revenue | 35.74B | 30.32B | 23.12B | 16.38B | 12.40B |
| Gross Profit | 3.48B | 2.68B | 2.03B | 1.35B | 1.10B |
| Gross Profit Ratio | 8.87% | 8.13% | 8.06% | 7.61% | 8.13% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.52B | 108.13M | 137.42M | 91.41M | 591.95M |
| Selling & Marketing | 44.88M | 272.85M | 248.62M | 132.21M | 3.59M |
| SG&A | 1.56B | 380.98M | 386.04M | 223.62M | 595.54M |
| Other Expenses | 1.09B | 55.14M | 8.86M | 6.05M | 0.00 |
| Operating Expenses | 2.65B | 2.29B | 1.92B | 1.28B | 970.27M |
| Cost & Expenses | 38.35B | 32.60B | 25.04B | 17.66B | 13.37B |
| Interest Income | 133.32M | 40.90M | 34.39M | 29.43M | 87.67M |
| Interest Expense | 656.84M | 489.72M | 260.95M | 163.80M | 0.00 |
| Depreciation & Amortization | 250.17M | 242.37M | 197.54M | 162.76M | 42.71M |
| EBITDA | 1.26B | 694.76M | 260.38M | 254.57M | 169.37M |
| EBITDA Ratio | 3.22% | 2.11% | 1.28% | 1.31% | 1.25% |
| Operating Income | 868.26M | 452.84M | 125.34M | 69.47M | 126.66M |
| Operating Income Ratio | 2.21% | 1.37% | 0.50% | 0.39% | 0.94% |
| Total Other Income/Expenses | -512.71M | -434.58M | -244.95M | -175.12M | -87.99M |
| Income Before Tax | 355.55M | -36.88M | -198.11M | -108.38M | 38.67M |
| Income Before Tax Ratio | 0.91% | -0.11% | -0.79% | -0.61% | 0.29% |
| Income Tax Expense | -42.44M | 74.16M | 96.28M | 45.16M | 25.81M |
| Net Income | 391.09M | -115.57M | -299.20M | -155.37M | 9.44M |
| Net Income Ratio | 1.00% | -0.35% | -1.19% | -0.88% | 0.07% |
| EPS | 8.99 | -2.66 | -6.88 | -3.57 | 0.22 |
| EPS Diluted | 8.99 | -2.66 | -6.88 | -3.57 | 0.22 |
| Weighted Avg Shares Out | 43.49M | 43.50M | 43.50M | 43.50M | 43.50M |
| Weighted Avg Shares Out (Dil) | 43.49M | 43.50M | 43.50M | 43.50M | 43.50M |
Source: https://incomestatements.info
Category: Stock Reports